IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSSO, Isabella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.809
NA - Nord America 2.794
AS - Asia 1.821
SA - Sud America 363
AF - Africa 36
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.740
PL - Polonia 1.565
CN - Cina 649
SG - Singapore 591
UA - Ucraina 315
BR - Brasile 314
HK - Hong Kong 202
DE - Germania 180
IT - Italia 163
VN - Vietnam 163
FI - Finlandia 143
FR - Francia 123
GB - Regno Unito 116
RU - Federazione Russa 73
TR - Turchia 55
IE - Irlanda 54
CA - Canada 33
IN - India 32
ID - Indonesia 25
BD - Bangladesh 22
AR - Argentina 16
BE - Belgio 16
KR - Corea 15
ZA - Sudafrica 15
MX - Messico 13
EC - Ecuador 12
ES - Italia 12
JP - Giappone 11
NL - Olanda 9
IQ - Iraq 8
AT - Austria 7
AU - Australia 7
MA - Marocco 7
PK - Pakistan 7
SE - Svezia 7
CO - Colombia 6
CZ - Repubblica Ceca 6
IR - Iran 6
PY - Paraguay 6
IL - Israele 5
JO - Giordania 5
KE - Kenya 5
OM - Oman 5
BG - Bulgaria 4
EU - Europa 4
CL - Cile 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
PS - Palestinian Territory 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
ET - Etiopia 2
KG - Kirghizistan 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
CH - Svizzera 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
Totale 7.834
Salva come PNG Salva come JPEG
Città #
Warsaw 1.565
Fairfield 308
Singapore 299
Ashburn 263
Jacksonville 242
Woodbridge 204
Hong Kong 201
Beijing 160
Seattle 136
Cambridge 126
Houston 125
Helsinki 108
Chandler 106
Princeton 104
Wilmington 100
Ann Arbor 88
Nanjing 87
New York 82
Brescia 71
Los Angeles 58
Dong Ket 54
Dublin 54
Istanbul 49
Ho Chi Minh City 40
Dearborn 39
Moscow 39
Buffalo 34
Munich 34
Dallas 33
Hanoi 33
Changsha 31
Nanchang 28
São Paulo 26
Des Moines 25
Milan 24
Chicago 23
Hebei 22
Jakarta 22
Redondo Beach 22
Shenyang 22
Shanghai 21
Phoenix 19
San Francisco 18
Jinan 17
The Dalles 17
Tianjin 17
Brussels 16
Jiaxing 16
Turku 16
Zhengzhou 14
London 13
Toronto 13
Guangzhou 12
San Diego 12
Kunming 11
Poplar 11
Rio de Janeiro 11
Tokyo 11
Johannesburg 10
Nuremberg 10
Curitiba 9
Frankfurt am Main 9
Brasília 8
Burlington 8
Hangzhou 8
Lappeenranta 8
Taizhou 8
Atlanta 7
Belo Horizonte 7
Brooklyn 7
Lancaster 7
Montreal 7
Ningbo 7
Orem 7
Taiyuan 7
Baltimore 6
Denver 6
Goiânia 6
Mexico City 6
Salt Lake City 6
Santa Clara 6
Stockholm 6
Augusta 5
Falkenstein 5
Fuzhou 5
Guayaquil 5
Haikou 5
Hanover 5
Hefei 5
Nairobi 5
Norwalk 5
Turin 5
Yuseong-gu 5
Amman 4
Ardabil 4
Asunción 4
Boardman 4
Bogotá 4
Chennai 4
Glasgow 4
Totale 5.611
Salva come PNG Salva come JPEG
Nome #
3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit 298
Effects of neuroinflammation on the regenerative capacity of brain stem cells 259
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex 257
Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation 257
Molecular insights and functional implication of LRRK2 dimerization 242
AMPA receptor regulation at the mRNA and protein level in rat primary cortical cultures 239
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging 231
Cross-talk between LRRK2 and PKA: Implication for Parkinson's disease? 224
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 222
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain 218
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate 216
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells 210
LRRK2 and neuroinflammation: Partners in crime in Parkinson's disease? 209
Exosomes-associated neurodegeneration and progression of Parkinson's disease 183
AMPA receptor regulation at the mRNA and protein level in rat primary cortical cultures 171
AMPA RECEPTOR PROPERTIES ARE MODULATED IN THE EARLY STAGES FOLLOWING PILOCARPINE-INDUCED STATUS EPILEPTICUS 152
ADAR therapy: a breakthrough against genetic disorders 138
The LRRK2 variant E193K prevents mitochondrial fission upon MPP+ treatment by altering LRRK2 binding to DRP1 135
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 130
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 125
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 121
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 117
Activation of neuronal differentiation in vivo and in vitro by means of synthetic peptide 115
The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications for Parkinson's disease 112
LRRK2 phosphorylation on synapsin I regulates glutamate release at presynaptic sites. 111
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils. 110
Parkinson’s disease LRRK2 modulates microglia physiology in health and disease 109
Exploring LRRK2-dependent clearance of α-synuclein pffs in glial cells via clusterin 106
EXPLORING LRRK2 BIOLOGY IN GLIAL CELLS: IMPLICATION FOR PARKINSON’S DISEASE 106
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 105
Leucine-rich repeat kinase-2 controls protein kinase A activation state through phosphodiesterase 4 102
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 99
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 94
Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease 93
3,6'-Dithiothalidomide, a TNF-α inhibitor, attenuates hippocampal neurogenesis and memory deficits in response to Aβ1-42 intracerebroventricular injection in mice 92
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 91
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 90
LRRK2 interacts and phosphorylates Synapsin I: implication for synaptic vesicle trafficking 90
LRRK2 is a positive modulator of neuroinflammation in microglia cells 88
miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome 85
3,6'-Dithiothalidomide treatment attenuates neuroinflammation, memory deficits and hippocampal neurogenesis in response to Aβ1-42 intracerebroventricular injection in mice 83
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 82
Leucine-rich repeat kinase-2 controls a-synuclein fibrils clearance in glial cells via clusterin 78
In vitro Glutamate treatment modify AMPA RNA editing and ADARs activity 77
Genetic and pharmacological evidence that G2019S LRRK2 confers hyperkinetic phenotype and prevents motor decline associated with aging 76
LRRK2 positively regulates inflammation and NF-kB p50 inhibitory signaling in microglia cells 75
Dopamine-Dependent Ketamine Modulation of Glutamatergic Synaptic Plasticity in the Prelimbic Cortex of Adult Rats Exposed to Acute Stress 75
LRRK2 kinase activity modulates neuroinflammation in microglia cells 74
Impact of COVID-19 on the oncological outcomes of colorectal cancer surgery in northern Italy in 2019 and 2020: multicentre comparative cohort study 73
LRRK2 Kinase Inhibition Attenuates Neuroinflammation and Cytotoxicity in Animal Models of Alzheimer's and Parkinson's Disease-Related Neuroinflammation 71
LRRK2 kinase activity modulates neuroinflammation in microglia cells 71
The protein kinase LRRK2 is involved in neurotransmitter release by interacting and phosphorylating synapsin I in nerve terminals. 69
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive factor (NSF) enhancing its ATPase activity 68
Transcriptional Profiling of Rat Prefrontal Cortex after Acute Inescapable Footshock Stress 68
Impact of Parkinson's disease related LRRK2 protein kinase activity at the pre-synaptic site 66
Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine 66
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 64
The group II p21-activated kinases as therapautic targets in LRRK2-related Parkinson’s disease 62
THE GROUP II P21-ACTIVATED KINASES AS THERAPAUTIC TARGETS IN LRRK2-RELATED PARKINSON'S DISEASE 59
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils 57
ADAR therapeutics to tackle neurodegenerative disorders 48
The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process 48
Functional impact of CYFIP2 RNA Editing on actin regulation, axon growth, and spinogenesis 41
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils 40
LRRK2 as a target for modulating immune system responses 39
RNA editing of CYFIP2 regulates in vitro neuronal development 38
ADAR therapeutics to tackle neurodegenerative disorders 35
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years 35
Uncovering the Role of Natural and Synthetic Small Molecules in Counteracting the Burden of α-Synuclein Aggregates and Related Toxicity in Different Models of Parkinson's Disease 29
LRRK2-Mediated Neuroinflammation-Induced Neuronal Dysfunctions in a Parkinson's and Alzheimer's Disease Cellular Model 20
EXPLORING LRRK2-TAU INTERPLAY IN PARKINSON’S DISEASE 14
The Emerging Role of the Molecular Chaperone Clusterin in Parkinson’s Disease 12
Poly-γ-glutamic acid alleviates cytotoxicity and inflammation induced by pre-formed fibrils of α-synuclein in murine primary astrocytes 6
Functional impact of CYFIP2 RNA editing on actin regulation, axon growth, and spinogenesis 4
Totale 7.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.557
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021612 0 0 0 0 0 99 48 99 102 103 93 68
2021/2022414 28 71 6 11 3 10 25 30 23 57 42 108
2022/2023392 69 8 15 33 31 95 5 25 70 5 18 18
2023/2024455 21 20 38 73 16 56 15 13 117 4 16 66
2024/20251.013 3 7 20 147 117 106 96 22 58 80 237 120
2025/20261.644 293 355 218 425 315 38 0 0 0 0 0 0
Totale 7.975